chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At about 3 AM on 5/17/2023, I woke up short of breath. I could feel that I had a very fast pulse. I got up and got my pulse oximeter. My pulse at the time was 105, and my blood oxygen level was 95. I was nervous at the time. The pulse stayed at around 100 (give or take) for about an hour. Over the next fifteen minutes, the pulse dropped into the high 80s. During the entire time, my blood oxygen stayed between 93 and 96. After my pulse dropped to the high 80s, I went back to bed. When I woke up, I was okay. At around 2:30 PM, I saw my NP and spoke to him about my situation. He examined my blood pressure, pulse, and oxygen saturation and conducted a complete ECG. He ordered bloodwork. The basic metabolic panel indicated that everything was within range, except chloride, which was 106. My magnesium level was normal. The ECG indicated normal sinus rhythm. A left anterior fascicular block was indicated by the ECG. The doctor instructed me to call back if I have a repetition of the event. He also told me that if I had chest pain or difficulty breathing, I should go to the ER.
Patient was administered an extra dose of the Pfizer 5-11 monovalent COVID-19 vaccine instead of the intended Pfizer 5-11 Bivalent Booster COVID-19 vaccine on 12/4/22 at 10:21am.   I called and informed patient's mother on 12/5/22 and she reported that patient is doing well except for some arm pain and hip pain. I will check in on the patient in a few weeks per mother's request.
Around mid afternoon April 7, I started having extreme pain in my right thumb all the way up to my shoulder, then within 24 -48 hours I had a major rash from right my thumb to shoulder. An extreme case of the shingles. Still have neurological pain and reduced motor skills in my right hand.
Mild diarrhea, mild nausea, mild stomach discomfort, and moderate abdominal cramping starting on April 9 and continuing through April 13 (not yet resolved as of this report).  Treated with daily pepto bismol, bland diet, and rest.
I felt as though I was going to vomit so i got up to go to the bathroom-on my way I fainted, falling into closet door breaking it & leaving hole in wall. My arm pain & body aches were severe. low grade temp & HA as well
Patient was dizzy, woozy, pale,  disoriented briefly . He sat on the floor for about 5 minutes, then we transferred to a chair. We gave him a cool cloth, crackers, juice and water. He waited in the pharmacy until we were sure he felt better and then left with his mother at 3:45 pm
On 7/17/02, early morning, complained of painful, red and swollen in left deltoid with large red area around DTAP immunization site. Per MD, can take Motrin for pain/temperature and apply ice to area.
inadvertently received a 4th dose of GARDASIL 9 at the age of 46 years old; inadvertently received a 4th dose of GARDASIL 9 at the age of 46 years old; No other AE; This spontaneous report was received from an office manager referring to a 46 years old patient of unknown gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.       On an unknown date at the age of 45 years old, the patient was vaccinated with 3 doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (strength, dose, route, lot # and expiration date were not reported) for prophylaxis. On an unknown date at the age of 46 years old, the patient inadvertently received a 4th dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (extra dose administered and product administered to patient of inappropriate age). No adverse event occurred.
Patient started with cough and congestion on 7/17/12. Had episodes of post-tussive emesis. Mother also with similar symptoms at the same time. Patient had been adequately vaccinated for pertussis as an infant (five doses of DTaP from 2001-2005). She was at the office receiving TDap booster at 11 year old well visit on 8/1/2012.
Information has been received from a physician concerning a male who was vaccinated with a first dose of PNEUMOVAX 0.5 mL.  Concomitant vaccination included a dose of influenza virus vaccine (unspecified) at the same visit.  The patient experienced an anaphylactic reaction after receiving PNEUMOVAX and the dose of influenza virus vaccine (unspecified).  The patient was seen at the emergency room and was treated with EPINEPHRINE.  At time of reporting, the patient had recovered.  The physician considered the anaphylactic reaction to be life threatening and other important medical event.  Additional information is not expected.
Rash on patients neck and chest area. Lasting from early Saturday (April 24) until Monday (April 26). Rash is still visible, but greatly improved. Low grade fever of 99 degrees or less. Symptoms were manageable by anti-histamine and Tylenol.
Narrative: Full body rash within 2 weeks of first dose of Pfizer -unsure of correlation
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Pharmacist).  A 76-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 5 (booster), single (Lot number: 6H9694) at the age of 75 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "osteoporosis" (unspecified if ongoing); "osteoarthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Took COVID test which gave positive results; (19Aug2023) Positive, notes: COVID self-test positive on 19Aug. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
she feels hot and cold; The sole of the left foot is hurting/ Her calves hurt; Intermittent pain throughout her body; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (she feels hot and cold), PAIN IN EXTREMITY (The sole of the left foot is hurting/ Her calves hurt) and PAIN (Intermittent pain throughout her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (she feels hot and cold), PAIN IN EXTREMITY (The sole of the left foot is hurting/ Her calves hurt) and PAIN (Intermittent pain throughout her body). At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (she feels hot and cold), PAIN IN EXTREMITY (The sole of the left foot is hurting/ Her calves hurt) and PAIN (Intermittent pain throughout her body) had not resolved.            No concomitant medications was reported. No treatment drug details was reported.
Pt received vaccine and did not tell clinic staff that she had a previous reaction to flu vaccine. Pt was in holding room being monitored for 15min post injection observation when she got flushed and started c/o tachycardia. Pt then started having nausea and vomiting followed by HTN and hive to palms of hands and wrist. Pt c/o of dizziness, urticaria, anxiety. Pt was given IM EpiPen into Right thigh and dexamethasone IM 2mg into Left deltoid. Pt responded well and was able to be discharged home to spouses care. Pt stable on discharge. Pt was monitored for 1 full hour prior to discharge.
This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX (Merck) which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. The patients did not seek medical attention. Follow up information has been received from the registered nurse who stated that it will take some time to get the VARIVAX (Merck) information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range as 6-12, units not reported) of unknown gender. On 27-OCT-2014, the patient was vaccinated with a dose of VARIVAX (Merck) which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficulty and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Chills; dry cough; no appetite; fatigue; pain at injection site; general malaise; general aches; temperature 102; This is a spontaneous report from a contactable nurse (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer-BioNTech ;lot number: EK9231) intramuscularly at right arm on 02Jan2021 at 07:45 A.M. at a single dose (dose number: 1) for COVID-19 immunization. Prior to vaccination, the patient was diagnosed with COVID-19 on 07Dec2020. No known allergies (no allergies to medications, food, or other products) and no other medical history. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medications the patient received within 2 weeks of vaccination were none. Facility where the most recent COVID-19 vaccine was administered was at hospital. The patient experienced adverse events included chills, temperature 102, general aches, fatigue, pain at injection site, dry cough, general malaise, no appetite. Temperature elevated till 03Jan2021, 6pm. Symptoms similar to what she experienced when diagnosed with covid-19 on 07Dec2020. All events with start date on 02Jan2021 at 06:00 P.M. The events were reported as non-serious. No treatment received for events. The outcome of events was resolving. Since the vaccination, the patient had not been tested for COVID-19.
3/4, admitted day after covid vaccine with SIRS. Patient presented to ED with fever/chills, weakness, and malaise on the morning of presentation, such that her son who is her caretaker could not get her up off the toilet on several occasions.  Patient had received the second of her Moderna Covid vaccinations the day prior and after workup in the ER and an observation stay, it is most likely that her presentation was a SIRS-type reaction to her vaccine.  She does have a resolving left arm cellulitis that her PCP has been managing and documenting improvement with and she was kept on antibiotics this stay, consistent with her outpatient treatment plan. She'll discharge home and cont to see her PCP for her left arm and chronic issues.
Client noticed  increased heart rate and light headed.  Taken to lay down on cot. b/p 148/96 heart rate 100                     1404 heart rate 86/ b/p 120/88    1410 feels pressure in her chest and stomach, sitting up on cot.  Reports that she is suffering from insomnia currently. Given snack and water stated she has only had ensure today. PC Dr., 1418; States she is doing better heart rate 106, SPO2  100% is opting to go to ER at this time.  Taken via wheel chair.
Around 4:45 pm on 1/28/21, patient reports swelling of lower lip on the left side only. The swelling continued to fill the entire bottom lip throughout the night. She denies swelling anywhere else and denies difficulty breathing at any point.
Patient reported stiff neck, head hurting and general unwell feeling that started the day of her second pfizer vaccination.
INJECTION SITE DEVELOPED A 2" RED RASH AREA (LEFT DELTOID). NO VESICLES/BREAKDOWN.  DENIES PAIN OR ITCH. NO SYSTEMIC SYMPTOMS.
Two hemorrhagic strokes; Clotting stroke; Experienced vision impairment in one eye; This is a spontaneous report from a non-contactable consumer. This non-contactable consumer reported for an adult female patient received bnt162b2 (PFIZER COVID-19 VACCINE), via an unspecified route of administration in 2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation; eptacog alfa (activated) (NOVOSEVEN RT), intravenous from an unspecified date (Batch/Lot number was not reported) at unspecified dose for factor VII deficiency. Medical history included ongoing factor VII deficiency. The concomitant medications were not reported. In 2021, the patient receiving therapy with NOVOSEVEN RT stated that she was advised to get the NOVOSEVEN RT infusion 48 hours prior to getting the PFIZER COVID-19 vaccine. The patient waited for 15 min after getting the COVID-19 vaccine for observation and was fine. However, as soon as the patient left she experienced two hemorrhagic strokes and one clotting stroke. The patient was hospitalized for the events. The patient experienced vision impairment in one eye due to the events. The action taken in response to the events for NOVOSEVEN RT was unknown. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
His vision turned black and his knees became weak. He felt nauseated and began to lose consciousness. He hung is head down until he could see. He made his way to his mother's bedroom leaning against the wall as his vision continued to be black. His mother laid in bed with him for 2 hours. He began to see white "streaks" across his vision. That lasted all day. He was tired and weak. He complained of a headache (5/10) and nausea throughout the day.
Papular rash developed 2/9/04. Seen by doctor 2/10/04 diagnosed chicken pox.
hospitalized for COVID pneumonia, and acute respiratory failure with hypoxia and hypercapnia on 11-30-2021
Vaccine was administer five days after the 30 day storage limit; No adverse event; Vaccine was administer five days after the 30 day storage limit; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administer five days after the 30 day storage limit), PRODUCT STORAGE ERROR (Vaccine was administer five days after the 30 day storage limit) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 06-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administer five days after the 30 day storage limit). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was administer five days after the 30 day storage limit) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administer five days after the 30 day storage limit), PRODUCT STORAGE ERROR (Vaccine was administer five days after the 30 day storage limit) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vaccine was administer five days after the 30 day storage limit) and PRODUCT STORAGE ERROR (Vaccine was administer five days after the 30 day storage limit).    This case contains information for the 2nd patient out of 2 adult patients as described by the reporter.  Concomitant medication was not reported. Treatment medication was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-710499, US-MODERNATX, INC.-MOD-2023-708810 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-710499:Case 1 of 2 patient, 06Feb2023 US-MODERNATX, INC.-MOD-2023-708810:Master case
102.8 fever, chills,  severe body aches, joint and muscle pain, brain fog, terrible headache, fatigue,  areas of previous body pain exasperated,
1815-patient slumped over in chair pale, opens eyes to voice, resp rate even and unlabored 1816-patient reports feeling "hot and sweaty", appears pale and diaphoretic, legs elevated, patient assisted to reclining position. BP 104/72, HR 84; RR16; O2 sat 98%. Patient given juice 1821- BP 105/78; HR 88; RR 16; O2 98%. Skin pink, warm, slightly diaphoretic. Ice applied to back of neck, cool cloth applied to forehead. Patient assisted to floor to lie flat with legs elevated. Patient denies SOB, itching, difficulty swallowing or breathing. Patient reports feeling better. MOC reports "she did this with her junior high shots". Discussed vasovagal precautions for injections. 1826- 104/68, HR-90; rr 16; O2 sat 100. skin warm and dry.  1828. Patient assisted to sitting position. Drinking water. Cap refill <3 sec, skin warm and pink. 1831- 106/66, HR 92; RR16; O2 100 1834 ambulated to chair, denies dizziness 1836 109/66, HR 96; RR16 , O2 99. Denies dizziness, reports feeling better.  1845- via wc to awaiting private vehicle. ER precautions reviewed and parent states understanding.
She was transferred to the hospital on 1/10/2022 with weakness, facial drop, inability to stand. Dx of Pontine Stroke. Returned to the facility 1/11/22 at baseline from Medical Center at baseline.
Fever, Nausea, Body Aches, Chills, Headache, Severe Arm pain
itching and redness going down arm, naseau, headache, head fog  50mg Benadryl
Received vaccines on 2/5/08.  On 2/6/08 mom called stating patient appeared pale, temperature 101.8, had a "shaking episode", crying a lot, fussy all night.
little soreness in the arm; feels slightly nauseous; Itching at the injection site minutes after the injection; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 12Mar2021 (Batch/Lot number was not reported) as 1st dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at time of vaccination. It was unknown if other vaccine was administered in four weeks. On 12Mar2021, the patient experienced itching at the injection site minutes after the injection, no other itches. The patient also experienced a little soreness in the arm today (a day after injection, 13Mar2021) and she also feels slightly nauseous but still fully able to do housework and to exercise. It was unknown if treatment was given; if patient had COVID prior vaccination and if patient was tested for COVID post vaccination. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Fever of 100.9; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100.9) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 100.9). At the time of the report, PYREXIA (Fever of 100.9) outcome was unknown.            Concomitant drug was not reported. Treatment medication was not reported.  Patient reported fever of 100.9.
I received the Pfizer booster on 12/6/2021.  I had significant lymphedema in my right armpit and right lateral breast after the injection.  This lasted for several days.  I was also very fatigued.  On December 16th, I felt like I was coming down with a cold.  I work at a SNF and had been tested for COVID and did a rapid test (all negative).  I went to the doctor's office to rule out strep and flu since I was on call that weekend.  I was negative for both.  I ran a fever on and off that weekend and had flu-like symptoms.  The next week, I still felt awful.  I had a respiratory panel run through Luxor and it came back positive for Human Metapneumovirus . I was quite ill and back and forth to the doctor several times (Solu-Medrol switched to Prednisone, Tessalon Pearls, Zithromax)  and had severe coughing and drainage for several weeks.  I was last at the doctor on January 11th due to acute pain in my right chest from coughing.  My cold symptoms had improved but my chest really hurt.  I had my second detailed chest x-ray with right rib detail and had two rib stress fractures.  I am now restricted from lifting more than 10 lbs for the next several weeks.
Information has been received from a 74 year old female with allergies to unspecified antibiotics and no pertinent medical history who on 07-JUN-2007 was vaccinated with a dose of Zostavax (Oka/Merck).  Concomitant therapy included pioglitazone hydrochloride (Actos).  "A few weeks after vaccination", the patient developed fatigue and severe muscle pain.  Unspecified medical attention was sought.  No lab studies were performed.  At the time of this report the patient had not recovered.  No further information was provided.  There was no product quality complaint involved.  No further information is available.
1 of 3 pts vaxed from the same lot# exp an inject site react which included redness, swelling & soreness; react lasted approx 4 days; no treatment given;
Information has been received from a health professional concerning a 38 year old Caucasian female who on 09/13/00, was vaccinated with the 1st dose of  Hepatitis B vaccine. On 09/13/00, the patient experienced arm pain. Follow up information indicated that when the patient was 18 she experienced "swelling" after a Tetanus booster. On 10/04/00 (previously reported as 10/13/00) the patient was vaccinated with her second dose of Hepatitis B vaccine, and experienced "immediate swelling-red, warm" and a hard knot that developed to the left side of the immunization shot site. Swelling spread about 1 inch with a knot. At the time of the initial report the upper arm was pretty swollen and ice was applied. The patient recovered within one week. No further information was available.